Please find enclosed the Standalone Audited Financial results for the Quarter and Year ended 31st March, 2026 along with the Auditors Report as approved by the Board of Directors at their ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
KMC Speciality Hospitals reported strong annual performance for FY2026 ending March 31. Revenue from operations grew 35% to ₹8,225.31 million from ₹6,093.48 million in the prior year. Profit after tax increased 37.6% to ₹1,757.12 million compared to ₹1,277.00 million. However, operating cash flow was negative at ₹941.59 million before working capital changes, indicating significant cash absorption. The company incurred finance costs of ₹438.82 million and depreciation of ₹730.79 million. Deloitte Haskins & Sells issued an unmodified (clean) audit opinion on the annual financial statements, confirming regulatory compliance and true fair view. The company operates in a single segment: Medical and Healthcare Services.
Strong top-line and bottom-line growth is positive for shareholders, but the negative operating cash flow despite healthy profits signals working capital stress that investors should monitor. The clean audit opinion removes audit quality concerns.